FINDRISC Calculator — Type 2 Diabetes
Predict your risk of developing type 2 diabetes over the next 10 years with the validated FINDRISC test (Lindström & Tuomilehto 2003). No blood draw — 8 questions, 2 minutes.
CalcVita. (2026). FINDRISC Calculator — Type 2 Diabetes. CalcVita. Retrieved October 17, 2026, from https://calcvita.com/en/calculators/findrisc
Suggested article
FINDRISC Explained: A 2-Minute Test That Beats Many Blood Tests for Diabetes Risk
The Finnish Diabetes Risk Score uses 8 simple questions — no needle — to estimate your 10-year chance of developing type 2 diabetes. Here is what each question measures, why it works, and what the prevention trials say to do with your score.
Read the full article →How FINDRISC works
The Finnish Diabetes Risk Score (FINDRISC) is a validated screening tool that estimates your risk of developing type 2 diabetes over the next 10 years. Adopted by the International Diabetes Federation and many national prevention programs. No blood draw needed: 8 questions give the answer.
Scoring system
Each of the 8 factors contributes 0 to 5 points according to its weight in diabetes risk; the total ranges from 0 to 26 points. The original study (Lindström & Tuomilehto 2003) derived the points for 7 of these factors (0–20 points) from a Finnish population sample followed for 10 years; the questionnaire in use today adds family history of diabetes (up to 5 points).
Risk tiers
- Low (<7 pts): ~1% — About 1% chance of developing diabetes in 10 years. Keep your lifestyle.
- Slightly elevated (7–11 pts): ~4% — ~4% probability. Consider improving diet and physical activity.
- Moderate (12–14 pts): ~17% — ~17% probability. Meaningful lifestyle changes recommended.
- High (15–20 pts): ~33% — ~33% probability. See your doctor for fasting glucose and a prevention plan.
- Very high (>20 pts): ~50% — ~50% probability. Immediate medical evaluation recommended.
How to lower your risk (Tier-1 evidence)
- Structured lifestyle program: 58% lower diabetes risk during the trial (mean follow-up 3.2 years) in people with impaired glucose tolerance (Finnish Diabetes Prevention Study). — Tuomilehto 2001 NEJM
- Lifestyle vs metformin: 58% reduction with lifestyle; 31% with metformin (US Diabetes Prevention Program). — Knowler 2002 NEJM
- Long-term sustained benefit: After a median of 7 years of total follow-up the risk was still 43% lower, and 36% lower in the years after counselling stopped (DPS follow-up). — Lindström 2006 Lancet
- Weight-loss goal (≥5% in DPS, ≥7% in DPP): The central goal of both programmes; in DPS the risk reduction was directly associated with the lifestyle changes achieved. — Tuomilehto 2001
- Moderate physical activity (≥30 min/day in DPS, ≥150 min/week in DPP): Core component of both interventions that cut diabetes risk by 58%. — Tuomilehto 2001
Scientific sources
- Lindström J, Tuomilehto J (2003). The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26(3):725–731.
- Tuomilehto J et al. (2001). Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. NEJM 344:1343–1350.
- Knowler WC et al. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. NEJM 346:393–403.
- Lindström J et al. (2006). Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 368:1673–1679.
More calculators
Keep exploring helpful tools
HOMA-IR insulin resistance
Insulin resistance from fasting glucose+insulin (Matthews 1985).
A1C to blood sugar (eAG)
Convert A1C to estimated average glucose using the ADAG formula (ADA 2024).
BMI calculator
Compute your BMI with WHO ranges and guidance.
Waist-to-hip ratio
Assess your fat distribution and cardiovascular risk with the waist-to-hip ratio.